Marco Ferrera

Title: Marco Ferrera: Innovator in CNS Disorder Treatments

Introduction

Marco Ferrera is a notable inventor based in San Donato Milanese, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating central nervous system (CNS) disorders. His innovative work has the potential to impact the lives of many individuals suffering from cognitive impairments.

Latest Patents

Ferrera holds a patent for "6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders." This invention relates to novel 6-Cycloalkyl-pyrazolopyrimidinones, which are designed to serve as active entities in medicaments. These compounds are particularly relevant for treating conditions associated with deficits in perception, concentration, learning, or memory. Such conditions may include Alzheimer's disease, schizophrenia, and other related disorders. The compounds exhibit PDE9 inhibiting properties, making them valuable in the development of effective treatments.

Career Highlights

Marco Ferrera is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company focuses on advancing research and development in the field of CNS disorders. With a patent portfolio that includes one significant patent, Ferrera is recognized for his contributions to medicinal chemistry.

Collaborations

Ferrera has collaborated with notable colleagues, including Niklas Heine and Christian Eickmeier. These collaborations have fostered an environment of innovation and have contributed to the advancement of research in CNS treatments.

Conclusion

Marco Ferrera's work in developing novel compounds for the treatment of CNS disorders highlights his commitment to improving patient outcomes. His innovative approach and collaboration with esteemed colleagues position him as a key figure in the pharmaceutical industry.